Robert J. Gould, See Remarks at Fulcrum Therapeutics, Inc. (FULC), sold 19,211 shares at $12.13 ($233K) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Open-market sale of $233k FULC by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.13 | 9,211 | $112K | 47.9% |
| 2 | $12.13 | 9,211 | $112K | 47.9% |
| 3 | $12.43 | 789 | $10K | 4.2% |
| Total | $12.14 avg | 19,211 | $233K | 100% |
| Filing → |
| FULC | SELL | 2026-01-06 | $356K | — | Filing → |
| FULC | SELL | 2025-11-21 | $165K | — | Filing → |
| FULC | SELL | 2023-01-13 | $101K | — | Filing → |